Status:
COMPLETED
Evaluation of the Reproducibility of Ablation Volumes at One Month After Microwave Treatment Compared to the Manufacturer's Abacus: on the Kidney, Liver and Lung
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Hepatic Tumor
Renal Tumor
Eligibility:
All Genders
18+ years
Brief Summary
Microwave thermal ablation (MO) is recognized as an alternative to surgery for the local-regional treatment of primary and secondary hepatic and renal tumors and for secondary pulmonary tumors in pati...
Detailed Description
The investigators have 2 years of experience and therefore propose to carry out a first retrospective study, on a cohort of about fifty patients, whose objective will be to compare the volume of in vi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- thermo-ablative treated patients with MO with the Covidian manufacturer
- primary hepatic or renal or secondary hepatic, renal or pulmonary tumor at the University Hospital of Nîmes between June 2016 and June 2018
- diagnosis and size of the tumour established on the basis of tomodensitometric (CT) or magnetic resonance (MRI) imaging.
- Exclusion Criteria
- patients with coagulation disorders
- patients with progressive infectious process contraindicating the procedure and/or for whom thermo-ablation equipment other than Covidien has been used
Exclusion
Key Trial Info
Start Date :
October 23 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 23 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04072224
Start Date
October 23 2018
End Date
October 23 2020
Last Update
January 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nîmes
Nîmes, France, 30029